An interventional study of Extracorporeal Shockwave Therapy (ESWT) and Massage Gun in Muscle Soreness, Delayed Onset Muscle Soreness and Athletic Injuries, sponsored by Sierra Varona SL. Not yet recruiting. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-24.
Sponsored by Sierra Varona SL · Not applicable, Interventional, and Prevention
The goal of this clinical trial is to evaluate the impact of various passive post-exercise recovery techniques on professional athletes. The main questions it aims to answer are:
Do passive recovery modalities significantly improve muscle oxygenation and tissue temperature immediately following high-intensity effort?
Which specific technique is most effective in reducing perceived pain, measured by the pressure pain threshold, and restoring muscle strength?
Researchers will compare six different therapeutic interventions-Transfer of Energy Capacitive and Resistive therapy, manual massage, intermittent negative pressure therapy, extracorporeal shockwave therapy, percussion therapy, and pneumatic pressotherapy-to determine which provides a superior immediate physiological and functional recovery effect.
Participants will:
Perform a high-intensity physical effort designed to induce peripheral fatigue.
Be randomly assigned to receive one of the six recovery protocols.
Undergo objective measurements immediately after the intervention, including near-infrared spectroscopy to assess muscle oxygen saturation, tissue thermography, algometry, and dynamometry.
This project is designed as a randomized, double-blind (outcome assessor and statistician), crossover clinical trial. The study aims to address the critical need for evidence-based recovery strategies in high-demand sports such as basketball, where muscle overload is a primary risk factor for injury.The investigation will focus on the immediate physiological and functional effects of six widely utilized physiotherapy modalities:Capacitive and Resistive Energy Transfer (TECAR) Therapy: Utilized to improve tissue perfusion and modulate inflammatory responses through deep endogenous thermotherapy.Percussive Massage Therapy: Applied via mechanical vibration to reduce muscular stiffness and enhance explosive force restoration.Extracorporeal Shockwave Therapy (ESWT): Evaluated for its capacity to enhance muscular microcirculation and accelerate immediate tissue metabolic activity.Intermittent Pneumatic Compression (Pressotherapy): Targeted at reducing perceived pain and the sensation of limb heaviness through mechanical fluid drainage.Intermittent Negative Pressure Therapy (Vacuum Therapy): Investigated for its role in localized blood flow enhancement and pain modulation.Manual Sports Massage: Defined as the traditional manual intervention for reducing perceived muscle soreness and improving soft tissue flexibility.Physiological monitoring will be conducted using Near-Infrared Spectroscopy (NIRS) to measure muscle oxygen saturation ($SmO_2$) and total hemoglobin, providing direct data on muscle oxidative metabolism. Functional outcomes will be assessed through pressure pain thresholds (PPT) via algometry and maximal isometric strength via dynamometry to determine the effectiveness of each technique in restoring neuromuscular homeostasis.The study will be conducted at the Sierra Varona Physiotherapy Clinic (Toledo, Spain) between February and March 2026..
256 studies on the registry are indexed under Myalgia; 46 are open to participants now.
This study's planned enrollment of 20 is below the median of 44 across 216 interventional studies indexed under Myalgia.
Browse Myalgia studies →Sierra Varona SL is the lead sponsor of 16 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Professional or Semi-professional athletes (specifically basketball players or endurance athletes) with a minimum of 2 years of competitive experience.
Aged between 18 and 35 years.
Healthy individuals with no current musculoskeletal injuries in the lower limbs.
Regular training frequency of at least 4-5 sessions per week.
Signed to participate in the study and follow the 6-week crossover protocol.
Commitment to maintain similar nutritional and sleep habits throughout the duration of the study.
Exclusion Criteria:
Presence of any acute or chronic injury in the gastrocnemius or Achilles tendon in the last 6 months.
for specific therapies:
For Shockwave Therapy: Blood clotting disorders or use of anticoagulants.
For TECAR/Diathermy: Metal implants in the lower limbs or pacemakers.
For Cupping: Acute skin infections or dermatological .
Consumption of performance-enhancing drugs, anti-inflammatory medication (NSAIDs), or stimulants that could affect muscle oxygenation (SmO2) or pain perception.
Recent surgery in the lower extremities (within the last year).
Inability to complete the standardized fatigue protocol or attend all 6 intervention sessions.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Application of radial shockwave therapy using the Longest LGT-2500S device. A total of 2,000 pulses will be delivered to the gastrocnemius muscle (medial and lateral heads) at a pressure of 2.5 bar and a frequency of 10-15 Hz. The intervention aims to improve local microcirculation and reduce myofascial stiffness.
Device: Extracorporeal Shockwave Therapy (ESWT)
Application of percussive massage using the Hyperice Hypervolt 2 Pro device. The intervention will last 5-10 minutes and will be applied to the gastrocnemius muscle at a frequency of 50 Hz (Level 3), focusing on the muscle-tendon junction to enhance neuromuscular recovery.
Device: Massage Gun
Application of diathermy using the Fisiowarm 300 system (Golden Star, Italy). The treatment will be administered for 15 minutes using a combination of capacitive and resistive modes at a frequency of 500 kHz. Intensity will be set at a thermal level (Type III) to promote deep vasodilation and metabolic clearance in the calf muscles.
Device: TECAR Therapy
A standardized sports massage session lasting 15-20 minutes will be performed by a senior physiotherapist with more than 20 years of experience in elite sports. The protocol will include deep effleurage, petrissage, and transverse friction techniques to alleviate muscle tension and improve blood flow in the gastrocnemius muscle.
Other: Manual Massage
Application of intermittent negative pressure using the Physium System (multimodal vacuum therapy). The protocol consists of a 10-minute session applied to the gastrocnemius area to decompress tissue layers, enhance lymphatic drainage, and modulate mechanoreceptors to reduce pain.
Device: cupping
Application of pressotherapy using the Hermes Professional system. The treatment will last 20 minutes with a sequential six-chamber inflation cycle at a pressure of 70-80 mmHg, aiming to accelerate venous return and reduce post-exercise edema.
Device: Pressotherapy
Application of acoustic pulses to the gastrocnemius muscle to modulate tissue mechanotransduction and improve local microcirculation.
Mechanical vibration applied to the calf muscles to promote myofascial release and neuromuscular recovery through high-frequency percussion.
Application of high-frequency electromagnetic energy (diathermy) to the lower limb to induce deep endogenous heat and accelerate metabolic waste removal.
Systematic manipulation of soft tissues using manual techniques (effleurage and petrissage) focused on reducing muscle tension and perceived soreness.
Controlled suction therapy applied to the gastrocnemius to create space between fascial layers and stimulate lymphatic and venous drainage.
External pneumatic compression through a sequential inflation system to facilitate venous return and reduce lower limb edema post-effort.
Muscle Oxygen Saturation (SmO2)
Measured using Moxy Monitor (Near-Infrared Spectroscopy - NIRS). It evaluates the percentage of hemoglobin/myoglobin oxygenated in the gastrocnemius muscle.
Time frame: immediately post-effort (fatigue), and immediately post-intervention (recovery).
Pressure Pain Threshold (PPT)
Measured using a digital pressure algometer. It quantifies the minimum pressure (in kg/cm²) at which a participant perceives the stimulus as painful in the gastrocnemius.
Time frame: immediately post-effort (fatigue), and immediately post-intervention (recovery).
Maximum Isometric Muscle Strength
Measured using a handheld dynamometer. It evaluates the peak force (in Newtons) during a maximum voluntary isometric contraction of the calf muscles.
Time frame: immediately post-effort (fatigue), and immediately post-intervention (recovery).
Muscle Surface Temperature
Measured using a digital infrared thermography camera. It assesses the changes in skin surface temperature over the gastrocnemius muscle area, reflecting changes in local blood flow.
Time frame: immediately post-effort (fatigue), and immediately post-intervention (recovery).
Participant Satisfaction and Perceived Recovery
Measured using a Visual Analog Scale (VAS) and a customized survey (Likert scale 1-5). Participants rate which recovery modality felt better and their perceived level of muscle readiness for a new effort.
Time frame: 5 minutes after each recovery intervention.
No study locations are listed for this record.
Plan to share: Yes — "De-identified individual participant data (including muscle oxygenation variables, pressure pain thresholds, and isometric strength values) will be made available upon reasonable request to the principal investigator. Data will be shared to facilitate meta-analyses or to verify the findings of this study, provided that the requesting researcher provides a methodologically sound proposal and signs a data use agreement to ensure athlete confidentiality."
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Jun 2026, 0 months later.
Of 101 non-industry interventional studies with no phase under Myalgia, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 16. This study's planned 0 months is below that.
Counting every sponsor, half of 111 studies reached it within 8 months; a quarter within 3 and three quarters within 16.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sierra Varona SL